Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort ascending
Oct
21
2021
$25 Billion Kroger/Albertsons Deal Fuels Antitrust Concerns MoginRubin
Oct
29
2020
Pharma: Consumer Groups, States Support Reviving Generic Drugs Antitrust Case Against AbbVie MoginRubin
Sep
18
2019
Consumer Groups and Unions Tell FTC: AbbVie-Allergen Merger Will Deny Access to More Effective and Affordable Drugs MoginRubin
Apr
10
2023
Khan's FTC Reportedly Reviving Price Discrimination Law to Investigate What Big Retailers Pay for Cola MoginRubin
Apr
14
2023
FTC Files Brief in Support of Private Antitrust Case Against Makers of Parkinson’s Drug MoginRubin
Mar
24
2023
Pfizer Expands Cancer Drug Portfolio with $43 Billion Biotech Acquisition MoginRubin
Feb
5
2020
Agencies’ Antitrust Suit Against Drug Maker Underscores Challenges of Bringing Biosimilars to Market MoginRubin
Oct
29
2020
Healthcare: Anticompetitive Tying Class Action Moves Forward Against Sutter Health MoginRubin
Mar
24
2023
Judge Approves $25M Settlement of Antitrust Action Against J&J for Allegedly Blocking Biosimilars MoginRubin
Nov
5
2019
Billion-Dollar Merger of DNA Sequencing Firms Opposed by U.K., Questioned in U.S. MoginRubin
Nov
20
2019
Anheuser-Busch InBev, Craft Brew Alliance Take Relationship to the Next Level MoginRubin
Jul
1
2020
Class of End-Payors Certified in Illegal Monopolization Suit Against Drug Maker Allergan MoginRubin
Jan
11
2022
7th Circuit: Is Each Transmission of Biometric Data a BIPA Violation? MoginRubin
Apr
14
2022
Full Ninth Circuit Removes Unwarranted Hurdles to Class Certification in Big Tuna Antitrust Case MoginRubin
May
19
2020
End of an Era: The U.S. is No Longer the Authority Figure for Multinational Mergers MoginRubin
Aug
18
2020
Altria, JUUL Call FTC’s Antitrust Complaint ‘Ill-Conceived’ and Deal Good for Competition, Consumers MoginRubin
Sep
21
2021
Changing Course, CMS Proposes to Repeal Medicare Coverage Pathway for FDA-Designated “Breakthrough Devices” Nelson Mullins
Oct
11
2021
HHS Rescinds Rule to Provide Insulin and Injectable Epinephrine at 340B Prices Nelson Mullins
Sep
14
2023
Stark Integrity Podcast: FCA, CARES Act, and Call Arrangements Episodes [Podcast] Nelson Mullins
Aug
15
2023
FDA Finalizes Informed Consent Guidance for Drug and Medical Device Clinical Investigations Nelson Mullins
Oct
3
2022
FDA Concludes Software Pre-Cert Pilot Program, Noting Federal Legislative Action is Needed Nelson Mullins
Feb
20
2023
Old North State Report – Feb. 20, 2023 Nelson Mullins
Jun
9
2023
Old North State Report – June 5, 2023 Nelson Mullins
Jul
18
2023
Hospital Price Transparency Changes in the Calendar Year 2024 Hospital Outpatient Prospective Payment System Proposed Rule Nelson Mullins
Sep
22
2021
Ushering in a New Era of OTC Drug Regulation, FDA Posts First Batch of “Deemed” Final Administrative Orders Nelson Mullins
Oct
26
2021
FDA Convenes Medical Device Workshop Focused on Artificial Intelligence and Machine Learning Transparency Nelson Mullins
Jul
18
2021
President Biden’s Recent Executive Order on Promoting Competition in the American Economy Highlights the Healthcare Sector Nelson Mullins
Jan
5
2023
Biden Administration Publishes Unified Agenda, Revealing FDA’s Planned Regulatory Actions for 2023 Nelson Mullins
Feb
27
2023
Old North State Report – Feb. 27, 2023 Nelson Mullins
Mar
28
2023
FDA Revamps Guidance Concerning Use of Electronic Systems, Records, and Signatures in Clinical Investigations Nelson Mullins
Apr
7
2023
Potential Nitrosamine Contamination Results in Another Voluntary Pharmaceutical Recall Nelson Mullins
Oct
2
2023
FDA Proposes New Rule to Regulate Laboratory Developed Tests Nelson Mullins
Jan
8
2024
Gold Dome Report – Legislative Day 1 (2024) Nelson Mullins
Mar
6
2023
Old North State Report – March 6, 2023 Nelson Mullins
Nov
9
2023
Proposed Changes to California Proposition 65 Warnings, Safe Harbor Methods & Content Nelson Mullins
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins